Melola Discovery

← Melola Discovery

Jurnal SINTA 1

In Silico Prediction of Isoliquiritigenin and Oxyresveratrol Compounds to BCL-2 dan VEGF-2 Receptors

Indonesian Journal of Cancer Chemoprevention · Vol. 10 No. 2 (2019) · hlm. 51–59

DOI
10.14499/indonesianjcanchemoprev10iss2pp51-59
ISSN
2355-8989, 2088-0197
Terbit
2019-06-30
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

Isoliquiritigenin and oxyresveratrol are compounds that have been reported to have anticancer activities. This study aimed to predict cytotoxic activity, toxicity and physicochemical properties of the compounds isoliquiritigenin and oxyresveratrol. Prediction of physicochemical properties referred to Lipinski rules of five using the pkCSM online tool. Prediction of compounds toxicity using Protox II online tool while ligand interaction with receptors using Molegro Virtual Docker (MVD). Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) (PDB: 2RL5) and B Cell Lymphoma BCL-2 (PDB: 4AQ3) were used as target cancer receptor proteins. In silico predictive results showed that oxyresveratrol and isoliquiritigenin complied with Lipinski rules of five, predictive values of LD50 between 500-2000 mg/kg respectively 1560 mg/kg and 1048 mg/kg. The docking result was in the form of bound energy described by Rerank Score (RS). A compound having a small RS value was predicted to have greater activity. RS of oxyresveratrol on 2RL5: -73.0413 and 4AQ3: -87.9985, while isoliquiritigenin on 2RL5: -68.0282 and 4AQ3: -78.5041. The cytotoxic activity of oxyresveratrol was also shown by hydrogen bonds in active amino acids (2RL5: Cys 919 in 4AQ3: Tyr 67). From docking results of both compounds, oxyreveratrol had greater activity than isoliquiritigenin to both target cancer receptor proteins and complied Lipinski rules of five and have a low toxicity.Keywords: cytotoxicity, toxicity, isoliquiritigenin, oxyresveratrol, in silico.

Jaringan kolaborasi para penulis

35 penulis · 108 tautan kepenulisan bersama · 32 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Islam Negeri Maulana Malik Ibrahim
  • State University of Malang
  • Universitas Trisakti
  • University of Brawijaya
  • Universitas Katolik Widya Mandala Surabaya
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Rahmi AnnisaUniversitas Islam Negeri Maulana Malik Ibrahim4
Arief SuryadinataUniversitas Islam Negeri Maulana Malik Ibrahim3
Nurlaili SusantiUniversitas Islam Negeri Maulana Malik Ibrahim2
Muhammad Ragib MustofaUniversitas Islam Negeri Maulana Malik Ibrahim2
Abdul Aziz HakimUniversitas Islam Negeri Maulana Malik Ibrahim2
Ach. NashichuddinUniversitas Islam Negeri Maulana Malik Ibrahim2
Muhammad ZainuddinUniversitas Islam Negeri Maulana Malik Ibrahim2
Ana RahmawatiAfiliasi tidak diketahui2
Jauza UlfahAfiliasi tidak diketahui2
Muhammad Firman AmrullohAfiliasi tidak diketahui2
Alif Firman FirdausyUniversitas Islam Negeri Maulana Malik Ibrahim2
Hibbatullah HibbbatullahUniversitas Islam Negeri Maulana Malik Ibrahim2
Dwi PuspitaState University of Malang2
Tanaya Jati Dharma DewiUniversitas Islam Negeri Maulana Malik Ibrahim1
Kesimira QonitaUniversitas Islam Negeri Maulana Malik Ibrahim1
Ferry SandraUniversitas Trisakti1
Farenza Okta KiranaUniversitas Islam Negeri Maulana Malik Ibrahim1
Ana RahmawatiUniversitas Islam Negeri Maulana Malik Ibrahim1
Trian Sidha MinggarwatiUniversitas Islam Negeri Maulana Malik Ibrahim1
Risma Aprinda KristantiUniversitas Islam Negeri Maulana Malik Ibrahim1
Erna SusantiAfiliasi tidak diketahui1
Syayida Roisatus ZahiroUniversity of Brawijaya1
Ermin RachmawatiState University of Malang1
Ahmad Ulfi BaihaqiAfiliasi tidak diketahui1
Maximus M. TaekUniversitas Katolik Widya Mandala Surabaya1
Hajar SugihantoroUniversitas Islam Negeri Maulana Malik Ibrahim1
Novia MaulinaUniversitas Islam Negeri Maulana Malik Ibrahim1
Sari Dewi SetyowatiUniversitas Islam Negeri Maulana Malik Ibrahim1
Salma Rizqika IrwanadiUniversitas Islam Negeri Maulana Malik Ibrahim1
Riza Ambar SariUniversitas Islam Negeri Maulana Malik Ibrahim1
Ziyana WalidahUniversitas Islam Negeri Maulana Malik Ibrahim1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">In Silico Prediction of Isoliquiritigenin and Oxyresveratrol Compounds to BCL-2 dan VEGF-2 Receptors</dc:title>
	<dc:creator>Mutiah, Roihatul</dc:creator>
	<dc:creator>Hariz, Muhammad Fawaz</dc:creator>
	<dc:creator>Indrawijaya, Yen Yen Ari</dc:creator>
	<dc:creator>Ma'arif, Burhan</dc:creator>
	<dc:description xml:lang="en-US">Isoliquiritigenin and oxyresveratrol are compounds that have been reported to have anticancer activities. This study aimed to predict cytotoxic activity, toxicity and physicochemical properties of the compounds isoliquiritigenin and oxyresveratrol. Prediction of physicochemical properties referred to Lipinski rules of five using the pkCSM online tool. Prediction of compounds toxicity using Protox II online tool while ligand interaction with receptors using Molegro Virtual Docker (MVD). Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) (PDB: 2RL5) and B Cell Lymphoma BCL-2 (PDB: 4AQ3) were used as target cancer receptor proteins. In silico predictive results showed that oxyresveratrol and isoliquiritigenin complied with Lipinski rules of five, predictive values of LD50 between 500-2000 mg/kg respectively 1560 mg/kg and 1048 mg/kg. The docking result was in the form of bound energy described by Rerank Score (RS). A compound having a small RS value was predicted to have greater activity. RS of oxyresveratrol on 2RL5: -73.0413 and 4AQ3: -87.9985, while isoliquiritigenin on 2RL5: -68.0282 and 4AQ3: -78.5041. The cytotoxic activity of oxyresveratrol was also shown by hydrogen bonds in active amino acids (2RL5: Cys 919 in 4AQ3: Tyr 67). From docking results of both compounds, oxyreveratrol had greater activity than isoliquiritigenin to both target cancer receptor proteins and complied Lipinski rules of five and have a low toxicity.Keywords: cytotoxicity, toxicity, isoliquiritigenin, oxyresveratrol, in silico.</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US">LP2M UIN Maulana Malik Ibrahim Malang</dc:contributor>
	<dc:date>2019-06-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/265</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev10iss2pp51-59</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 10, No 2 (2019); 51-59</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/265/183</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Indonesian Journal of Cancer Chemoprevention</dc:rights>
</oai_dc:dc>